Your browser doesn't support javascript.
loading
Safety and tolerability of sodium-glucose cotransporter-2 inhibitors in bridge-to-transplant patients supported with centrifugal-flow left ventricular assist devices.
Chavali, Sanjay; Barua, Sumita; Adji, Audrey; Robson, Desiree; Raven, Lisa M; Greenfield, Jerry R; Eckford, Hunter; Macdonald, Peter S; Hayward, Christopher S; Muthiah, Kavitha.
Affiliation
  • Chavali S; St Vincent's Hospital, Sydney, Australia; School of Clinical Medicine, St Vincent's Campus, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
  • Barua S; St Vincent's Hospital, Sydney, Australia; School of Clinical Medicine, St Vincent's Campus, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia; Victor Chang Cardiac Research Institute, Sydney, Australia.
  • Adji A; St Vincent's Hospital, Sydney, Australia; School of Clinical Medicine, St Vincent's Campus, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia; Victor Chang Cardiac Research Institute, Sydney, Australia.
  • Robson D; St Vincent's Hospital, Sydney, Australia.
  • Raven LM; St Vincent's Hospital, Sydney, Australia; School of Clinical Medicine, St Vincent's Campus, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia; Clinical Diabetes, Appetite and Metabolism Laboratory, Garvan Institute of Medical Research, Sydney, Australia.
  • Greenfield JR; St Vincent's Hospital, Sydney, Australia; School of Clinical Medicine, St Vincent's Campus, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia; Clinical Diabetes, Appetite and Metabolism Laboratory, Garvan Institute of Medical Research, Sydney, Australia.
  • Eckford H; St Vincent's Hospital, Sydney, Australia; Victor Chang Cardiac Research Institute, Sydney, Australia.
  • Macdonald PS; St Vincent's Hospital, Sydney, Australia; School of Clinical Medicine, St Vincent's Campus, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia; Victor Chang Cardiac Research Institute, Sydney, Australia.
  • Hayward CS; St Vincent's Hospital, Sydney, Australia; School of Clinical Medicine, St Vincent's Campus, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia; Victor Chang Cardiac Research Institute, Sydney, Australia.
  • Muthiah K; St Vincent's Hospital, Sydney, Australia; School of Clinical Medicine, St Vincent's Campus, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia; Victor Chang Cardiac Research Institute, Sydney, Australia. Electronic address: kavitha.muthiah@svha.org.au.
Int J Cardiol ; 391: 131259, 2023 11 15.
Article in En | MEDLINE | ID: mdl-37574028
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart-Assist Devices / Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors / Heart Failure Limits: Humans Language: En Journal: Int J Cardiol Year: 2023 Document type: Article Affiliation country: Australia Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart-Assist Devices / Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors / Heart Failure Limits: Humans Language: En Journal: Int J Cardiol Year: 2023 Document type: Article Affiliation country: Australia Country of publication: Netherlands